Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for the response to PPARγ agonist treatment

Overview of attention for article published in Diabetologia, October 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 37,388 followers.

Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for… https://t.co/sKYz5Y6tSc https://t.co/LVQgpGFgC3

RT @DiabetologiaJnl: #Endotrophin identified as biomarker to predict successful outcome of anti-diabetic treatment regimen #schererlab http…

RT @DiabetologiaJnl: #Endotrophin identified as biomarker to predict successful outcome of anti-diabetic treatment regimen #schererlab http…

#Endotrophin identified as biomarker to predict successful outcome of anti-diabetic treatment regimen #schererlab https://t.co/4lS9JjRdmB

Endotrophin, a predictive biomarker for the response to PPARγ agonist treatment. https://t.co/QNAwyJVhXR

#Endotrophin identified as biomarker to predict successful outcome of anti-diabetic treatment regimen #schererlab https://t.co/4lS9Jk8OLb

#Endotrophin identified as biomarker to predict successful outcome of anti-diabetic treatment regimen #schererlab https://t.co/4lS9JjRdmB